Acyl-coenzyme A: Cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7α-hydroxylase in cultured rat hepatocytes and in vivo in the rat
Open Access
- 1 August 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 30 (2) , 491-500
- https://doi.org/10.1002/hep.510300230
Abstract
Acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitors are currently in clinical development as potential lipid-lowering and antiatherosclerotic agents. We investigated the effect of avasimibe (Cl- 1011), a novel ACAT inhibitor, on bile acid synthesis and cholesterol 7α-hydroxylase in cultured rat hepatocytes and rats fed different diets. Avasimibe dose-dependently decreased ACAT activity in rat hepatocytes in the presence and absence of β-migrating very low-density lipoproteins (βVLDL) (by 93% and 75% at 10 μmol/L) and reduced intracellular storage of cholesteryl esters. Avasimibe (3 μmol/L) increased bile acid synthesis (2.9-fold) after preincubation with βVLDL and cholesterol 7α-hydroxylase activity (1.7- and 2.6-fold, with or without βVLDL), the latter paralleled by a similar induction of its messenger RNA (mRNA). Hepatocytes treated with avasimibe showed a shift from storage and secretion of cholesteryl esters to conversion of cholesterol into bile acids. In rats fed diets containing different amounts of cholesterol and cholate, avasimibe reduced plasma cholesterol (by 52% to 71%) and triglyceride levels (by 28% to 62%). Avasimibe did not further increase cholesterol 7α-hydroxylase activity and mRNA in cholesterol-fed rats, but prevented down-regulation by cholate. Avasimibe did not affect sterol 27-hydroxylase and oxysterol 7α-hydroxylase, 2 enzymes in the alternative pathway in bile acid synthesis. No increase in the ratio of biliary excreted cholesterol to bile acids was found, indicating that ACAT inhibition does not result in a more lithogenic bile. Avasimibe increases bile acid synthesis in cultured hepatocytes by enhancing the supply of free cholesterol both as substrate and inducer of cholesterol 7α-hydroxylase. These effects may partially explain the potent cholesterol-lowering effects of avasimibe in the rat.Keywords
This publication has 53 references indexed in Scilit:
- 2.P.55 ACAT inhibition by CI-1011 lowers plasma triglycerides in rats by enhancing the clearance of VLDLAtherosclerosis, 1997
- Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.Journal of Clinical Investigation, 1994
- Bile acid synthesis in hamster hepatocytes in primary culture: Sources of cholesterol and comparison with other speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Role of newly synthesized cholesterol or its metabolites on the regulation of bile acid biosynthesis after short-term biliary diversion in the ratHepatology, 1993
- On the mechanism of stimulation of cholesterol 7α-hydroxylase by dietary cholesterolBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Potential bile acid precursors in plasma—Possible indicators of biosynthetic pathways to cholic and chenodeoxycholic acids in manThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- The role of acyl-CoA:cholesterol acyltransferase in the metabolism of free cholesterol to cholesteryl esters or bile acids in primary cultures of rat hepatocytesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Secretion of Cholesterol-Rich Lipoproteins by Perfused Livers of Hypercholesterolemic RatsJournal of Clinical Investigation, 1979
- Effect of lymphatic drainage on 7α-hydroxylation of cholesterol in rat liverBiochemical and Biophysical Research Communications, 1978
- Regulation of Cholesterol Metabolism in the DogJournal of Clinical Investigation, 1973